Leveraging biologics manufacturing capacity to supply life-improving or life-saving medicines is key to a flexible supply chain that can respond to unforeseen demand changes. This webinar examines how ...

Traditional biologics manufacturing, reliant on sequential batch processing operations, faces significant limitations such as low productivity, lengthy processing times, and frequent manual ...

Pilot runs in Europe and South America show breakthrough efficiency in monoclonal antibody production with unprecedented cost savings and scalability using Stämm's bubble-free continuous laminar flow ...

Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to ...

PRINCETON, N.J. and HANGZHOU, China, Dec. 28, 2025 (GLOBE NEWSWIRE) -- Transcenta Holding Limited (HKEX: 06628) (“Transcenta Therapeutics”), a global clinical stage biopharmaceutical company with ...

RIO RANCHO, N.M.--(BUSINESS WIRE)--Nature’s Toolbox (NTx), a life sciences company developing next-generation platforms for RNA and protein manufacturing, today announced the full commercial ...

The process of biomanufacturing requires engineering microbes to produce useful chemicals and materials from carbon neutral processes. But current biomanufacturing cannot get beyond small production ...

Transcenta Holding Limited (Transcenta Therapeutics), a global clinical stage biopharmaceutical company, announced it has entered into a strategic collaboration and non-exclusive licensing agreement ...